Visceral adipose tissue visfatin in nonalcoholic fatty liver disease

Background. Visfatin is a novel adipocytokine predominantly expressed and secreted by visceral adipose tissue. It is realized for its multiple functions of central importance in NAD biosynthesis, innate immunity and inflammation. Its phosphoribosyl transferase activity regulates cellular energetics...

Full description

Bibliographic Details
Main Authors: Radhika Gaddipati, Sasikala Mitnala, PhD, Nagarajarao Padaki, Rathindra Mohan Mukherjee, Anuradha Sekaran, Magnus Jayaraj-Mansard, Pradeep Rabella, Venkat Rao-Guduru, Nageshwar Reddy-Duwuru
Format: Article
Language:English
Published: Elsevier 2010-07-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119316357
_version_ 1818607761328439296
author Radhika Gaddipati
Sasikala Mitnala, PhD
Nagarajarao Padaki
Rathindra Mohan Mukherjee
Anuradha Sekaran
Magnus Jayaraj-Mansard
Pradeep Rabella
Venkat Rao-Guduru
Nageshwar Reddy-Duwuru
author_facet Radhika Gaddipati
Sasikala Mitnala, PhD
Nagarajarao Padaki
Rathindra Mohan Mukherjee
Anuradha Sekaran
Magnus Jayaraj-Mansard
Pradeep Rabella
Venkat Rao-Guduru
Nageshwar Reddy-Duwuru
author_sort Radhika Gaddipati
collection DOAJ
description Background. Visfatin is a novel adipocytokine predominantly expressed and secreted by visceral adipose tissue. It is realized for its multiple functions of central importance in NAD biosynthesis, innate immunity and inflammation. Its phosphoribosyl transferase activity regulates cellular energetics and NAD dependent enzymes such as SIRTUINS. Although its expression in various tissues and circulating levels are documented, visceral visfatin levels in Nonalcoholic fatty liver disease (NAFLD) patients have not been reported.Objective. The aim of the present study was to assess visceral adipose tissue visfatin levels in NAFLD.Materials and methods. A total of 115 patients undergoing diagnostic laparoscopy were recruited in the study and categorized into two groups based on standard criteria for NAFLD. Visceral adipose tissue TNF-α, IL-6 and visfatin levels were measured by ELISA. Blood glucose, lipids, liver enzymes and non esterified fatty acids (NEFA) were estimated using standard procedures. Formalin fixed, Hematoxylene Eosin stained liver biopsy specimens were examined for the presence of steatosis and the degree of steatosis was ascertained as per Brunt’s classification.Results. The visceral visfatin level declined significantly (P < 0.001) in all groups of NAFLD as compared to non NAFLD group, while plasma NEFA level increased with progressive steatosis (P < 0.02). Significant increase in TNF a was observed in all groups of NAFLD, while IL-6 increased in NASH only.Conclusion. A significant decline in visceral adipose tissue visfatin level was found to be associated with degree of steatosis in NAFLD patients.
first_indexed 2024-12-16T14:31:53Z
format Article
id doaj.art-a53c971602694d27b101f34cf55553df
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-16T14:31:53Z
publishDate 2010-07-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-a53c971602694d27b101f34cf55553df2022-12-21T22:28:13ZengElsevierAnnals of Hepatology1665-26812010-07-0193266270Visceral adipose tissue visfatin in nonalcoholic fatty liver diseaseRadhika Gaddipati0Sasikala Mitnala, PhD1Nagarajarao Padaki2Rathindra Mohan Mukherjee3Anuradha Sekaran4Magnus Jayaraj-Mansard5Pradeep Rabella6Venkat Rao-Guduru7Nageshwar Reddy-Duwuru8Institute of Basic Sciences and Translational Research, Asian Health Care FoundationInstitute of Basic Sciences and Translational Research, Asian Health Care Foundation; Correspondence and reprint request:Asian Institute of GastroenterologyInstitute of Basic Sciences and Translational Research, Asian Health Care FoundationAsian Institute of GastroenterologyAsian Institute of GastroenterologyAsian Institute of GastroenterologyAsian Institute of GastroenterologyAsian Institute of GastroenterologyBackground. Visfatin is a novel adipocytokine predominantly expressed and secreted by visceral adipose tissue. It is realized for its multiple functions of central importance in NAD biosynthesis, innate immunity and inflammation. Its phosphoribosyl transferase activity regulates cellular energetics and NAD dependent enzymes such as SIRTUINS. Although its expression in various tissues and circulating levels are documented, visceral visfatin levels in Nonalcoholic fatty liver disease (NAFLD) patients have not been reported.Objective. The aim of the present study was to assess visceral adipose tissue visfatin levels in NAFLD.Materials and methods. A total of 115 patients undergoing diagnostic laparoscopy were recruited in the study and categorized into two groups based on standard criteria for NAFLD. Visceral adipose tissue TNF-α, IL-6 and visfatin levels were measured by ELISA. Blood glucose, lipids, liver enzymes and non esterified fatty acids (NEFA) were estimated using standard procedures. Formalin fixed, Hematoxylene Eosin stained liver biopsy specimens were examined for the presence of steatosis and the degree of steatosis was ascertained as per Brunt’s classification.Results. The visceral visfatin level declined significantly (P < 0.001) in all groups of NAFLD as compared to non NAFLD group, while plasma NEFA level increased with progressive steatosis (P < 0.02). Significant increase in TNF a was observed in all groups of NAFLD, while IL-6 increased in NASH only.Conclusion. A significant decline in visceral adipose tissue visfatin level was found to be associated with degree of steatosis in NAFLD patients.http://www.sciencedirect.com/science/article/pii/S1665268119316357NAFLDTNF αNEFAVisceral visfatin
spellingShingle Radhika Gaddipati
Sasikala Mitnala, PhD
Nagarajarao Padaki
Rathindra Mohan Mukherjee
Anuradha Sekaran
Magnus Jayaraj-Mansard
Pradeep Rabella
Venkat Rao-Guduru
Nageshwar Reddy-Duwuru
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
Annals of Hepatology
NAFLD
TNF α
NEFA
Visceral visfatin
title Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
title_full Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
title_fullStr Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
title_full_unstemmed Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
title_short Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
title_sort visceral adipose tissue visfatin in nonalcoholic fatty liver disease
topic NAFLD
TNF α
NEFA
Visceral visfatin
url http://www.sciencedirect.com/science/article/pii/S1665268119316357
work_keys_str_mv AT radhikagaddipati visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT sasikalamitnalaphd visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT nagarajaraopadaki visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT rathindramohanmukherjee visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT anuradhasekaran visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT magnusjayarajmansard visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT pradeeprabella visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT venkatraoguduru visceraladiposetissuevisfatininnonalcoholicfattyliverdisease
AT nageshwarreddyduwuru visceraladiposetissuevisfatininnonalcoholicfattyliverdisease